Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue

Details for Australian Patent Application No. 2004240247 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Ehlers, Mario R W; Coolidge, Thomas R

Agent Freehills

Pub. Number AU-A-2004240247

Parent 777019

Filing date 21 December 2004

Wipo publication date 20 January 2005

Acceptance publication date 31 July 2008

International Classifications

A61K 038/00 Medicinal preparations containing peptides

Event Publications

13 January 2005 Complete Application Filed

20 January 2005 Application Open to Public Inspection

  Published as AU-A-2004240247

31 July 2008 Application Accepted

  Published as AU-A-2004240247

27 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004240248-Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13

2004240246-Method and Apparatus for Authenticating and Verifying Communication on a Network of Gaming Devices